Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 3:00 pm Sale | 13G | Sutro Biopharma, Inc. STRO | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -2,708,975 (Position Closed) | View |
| 2023-02-14 11:45 am Purchase | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 3,347,946 5.8% | 187,530 (+5.93%) | View |
| 2023-02-13 10:56 am Purchase | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 5,565,099 9.7% | 3,091,304 (+124.96%) | View |
| 2023-02-10 4:00 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | Rubric Capital Management LP | 3,211,872 5.59% | 3,211,872 (New Position) | View |
| 2023-02-07 2:55 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 4,860,140 8.5% | 1,160,097 (+31.35%) | View |
| 2023-02-01 1:09 pm Sale | 13G | Sutro Biopharma, Inc. STRO | FRANKLIN RESOURCES INC BEN | 2,838,135 4.9% | -429,812 (-13.15%) | View |
| 2023-01-23 4:31 pm Sale | 13G | Sutro Biopharma, Inc. STRO | MILLENNIUM MANAGEMENT LLC | 1,369,021 2.4% | -1,053,652 (-43.49%) | View |
| 2022-07-08 4:19 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | MILLENNIUM MANAGEMENT LLC | 2,422,673 5.2% | 2,422,673 (New Position) | View |
| 2022-02-14 12:00 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | EVENTIDE ASSET MANAGEMENT LLC | 2,708,975 5.9% | 338,000 (+14.26%) | View |
| 2022-02-11 4:49 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 2,473,795 5.4% | 65,400 (+2.72%) | View |
| 2022-02-04 1:45 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | FRANKLIN RESOURCES INC BEN | 3,267,947 7.1% | 3,267,947 (New Position) | View |
| 2022-02-02 7:18 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 3,700,043 8% | 982,114 (+36.13%) | View |
| 2022-01-18 5:18 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 3,160,416 6.8% | 1,306,254 (+70.45%) | View |
| 2021-12-10 4:31 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 2,408,395 5.2% | 2,408,395 (New Position) | View |
| 2021-04-05 5:28 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | BRISTOL MYERS SQUIBB CO BMY | 1,726,197 3.8% | 1,726,197 (New Position) | View |
| 2021-02-16 4:30 pm Sale | 13G | Sutro Biopharma, Inc. STRO | CITADEL ADVISORS LLC | 1,301,804 2.9% | -427,172 (-24.71%) | View |
| 2021-02-16 4:22 pm Sale | 13G | Sutro Biopharma, Inc. STRO | Ridgeback Capital Investments L.P. | 1,144,979 2.5% | -869,708 (-43.17%) | View |
| 2021-02-16 08:57 am Sale | 13G | Sutro Biopharma, Inc. STRO | Alta Partners VIII L.P. | 0 0% | -1,948,516 (Position Closed) | View |
| 2021-02-12 5:23 pm Sale | 13G | Sutro Biopharma, Inc. STRO | EcoR1 Capital LLC | 93,416 0.2% | -2,235,076 (-95.99%) | View |
| 2021-02-12 4:25 pm Sale | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 1,854,162 4.1% | -514,230 (-21.71%) | View |